Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:administeredBy |
gptkb:vemurafenib
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:L01XE39
|
| gptkbp:brand |
gptkb:Cotellic
|
| gptkbp:CASNumber |
934660-93-2
|
| gptkbp:developedBy |
gptkb:Genentech
|
| https://www.w3.org/2000/01/rdf-schema#label |
cobimetinib
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
MEK inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue rash photosensitivity |
| gptkbp:target |
gptkb:MEK1
gptkb:MEK2 |
| gptkbp:usedFor |
melanoma
|
| gptkbp:bfsParent |
gptkb:MEK1
gptkb:MEK_inhibitors |
| gptkbp:bfsLayer |
6
|